Tovorilimab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tovorilimab, covering 2026-04-07 to 2026-04-07. Get the full timeline:
Most recent: Clinical Trial Update: Iparomlimab Plus Tovorilimab Combined With Bevacizumab and Chemotherapy as First-Line Treatment for Advanced Mesothelioma [Phase 2]